Zai Lab (ZLAB) Current Assets (2016 - 2026)
Zai Lab (ZLAB) posted Current Assets of $944.7 million for Q1 2026, down 7.31% sequentially from $1.0 billion in Q4 2025, and down 9.32% YoY from $1.0 billion in Q1 2025.
Zai Lab (ZLAB) Current Assets (2016 - 2026) Analysis & Trends
Zai Lab has reported Current Assets for 11 years, with the latest figure at $944.7 million in Q1 2026.
- Quarterly Current Assets fell 9.32% year-over-year to $944.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $944.7 million (down 9.32% YoY) and the FY2025 annual result came in at $1.0 billion, down 2.97% from the prior year.
- Current Assets fell to $944.7 million in Q1 2026 per ZLAB's latest filing, from $1.0 billion in the prior quarter.
- Over five years, Current Assets peaked at $1.4 billion in Q1 2022 and troughed at $860.5 million in Q3 2024.
- A 5-year average of $1.0 billion and a median of $1.0 billion in 2025 frame the typical range for Current Assets.
- The widest YoY moves for Current Assets: up 32.79% in 2022, down 26.15% in 2022.
- Over 5 years, Current Assets stood at $1.1 billion in 2022, then dropped by 16.43% to $939.6 million in 2023, then grew by 11.8% to $1.1 billion in 2024, then declined by 2.97% to $1.0 billion in 2025, then decreased by 7.31% to $944.7 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $944.7 million, $1.0 billion, and $1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 914.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 914.04 Mn |
| Mar 31, 2026 | 944.73 Mn |
| Dec 31, 2025 | 1.02 Bn |
| Sep 30, 2025 | 1.03 Bn |
| Jun 30, 2025 | 1.03 Bn |
| Mar 31, 2025 | 1.04 Bn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 860.55 Mn |
| Jun 30, 2024 | 869.92 Mn |
| Mar 31, 2024 | 888.64 Mn |
| Dec 31, 2023 | 939.61 Mn |
| Sep 30, 2023 | 959.73 Mn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 1.12 Bn |
| Sep 30, 2022 | 1.21 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Mar 31, 2022 | 1.39 Bn |
| Dec 31, 2021 | 1.50 Bn |
| Sep 30, 2021 | 1.62 Bn |